A cost benefit analysis of a virtual overdose monitoring service/mobile overdose response service: the national overdose response service

Author:

Rioux William,Enns Benjamin,Jackson Jennifer,Quereshi Hena,Irvine Mike,Ghosh S. Monty

Abstract

Abstract Background The overdose crisis continues across Canada which calls for novel harm reduction strategies. Previous research indicates that a majority of eHealth solutions are cost-effective however current literature on the cost-benefit of eHealth for harm reduction is sparse. The National Overdose Response Service (NORS) is a Canada-wide telephone-based harm reduction service. Service users can call the phone number and connect to a peer who can virtually monitor the substance use session and dispatch appropriate interventions in the case of overdose. Objectives of the research/project We aim to assess the cost-benefit of NORS by comparing the estimated cost-savings from prevented overdose mortality to the operating costs of the program, alongside healthcare costs associated with its operation. Methods Data around systems costs and operational costs were gathered for our calculations. Our primary outcome was cost-benefit ratios, derived from estimates and models of mortality rates in current literature and value of life lost. We presented our main results across a range of values for costs and the probability of death following an unwitnessed overdose. These values were utilized to calculate cost-benefit ratios and value per dollar spent on service provision by NORS over the length of the program’s operation (December 2020–2022). Results Over the total funded lifespan of the program, and using a Monte Carlo estimate, the benefit-to-cost ratio of the NORS program was 8.59 (1.53–15.28) per dollar spent, depending on estimated mortality rates following unwitnessed overdose and program operation costs. Further, we conservatively estimate that early community-based naloxone intervention results in healthcare system savings of $4470.82 per overdose response. Conclusions We found the NORS program to have a positive benefit-to-cost ratio when the probability of death following an unwitnessed overdose was greater than 5%. NORS and potentially other virtual overdose monitoring services have the potential to be cost-effective solutions for managing the drug poisoning crisis.

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Health Policy

Reference45 articles.

1. Government of Alberta. COVID-19 info for Albertans [Internet]. [cited 2023 Jul 31]. Available from: https://www.alberta.ca/coronavirus-info-for-albertans.aspx.

2. Lee Y, Lui LMW, Brietzke E, Liao Y, Lu C, Ho R, et al. Comparing mortality from covid-19 to mortality due to overdose: a micromort analysis. J Affect Disord. 2022;296:514–21.

3. Federal, provincial, and territorial Special Advisory Committee on the Epidemic of Opioid Overdoses. Opioid- and Stimulant-related Harms in Canada. [Internet]. Ottawa: Public Health Agency of Canada; 2023 [cited 2023 Jul 31]. Available from: https://health-infobase.canada.ca/substance-related-harms/opioids-stimulants/.

4. Canadian Substance Use Costs and Harms Scientific Working Group. Canadian substance use costs and harms 2015–2017. [Internet]. Ottawa, Ont.: Canadian Centre on Substance Use and Addiction.; 2020 [cited 2023 Mar 1]. Available from: https://csuch.ca/publications/CSUCH-Canadian-Substance-Use-Costs-Harms-Report-2020-en.pdf.

5. Recovery Centers of America. Economic cost of substance abuse disorder in the United States, 2019 [Internet]. [cited 2022 Dec 12]. Available from: https://recoverycentersofamerica.com/resource/economic-cost-of-substance-abuse-disorder-in-united-states-2019/.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3